332
Participants
Start Date
October 22, 2021
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2027
CAM2029
CAM2029 (octreotide subcutaneous depot) 20 mg will be administered every 2 weeks as a subcutaneous injection
Octreotide LAR
Octreotide LAR 30 mg will be administered every 4 weeks as an intramuscular injection
Lanreotide ATG
Lanreotide ATG 120 mg will be administered every 4 weeks as a deep subcutaneous injection
Memorial Sloan-Kettering Cancer Center, New York
The Mount Sinai Hospital, The Bronx
White Plains Hospital - Center for Cancer Care, White Plains
Mayo Clinic Hospital - Florida, Jacksonville
Anderson Family Cancer Institute, Jupiter
University of Kentucky (UK) - Markey Cancer Center, Lexington
Mayo Clinic Rochester, Rochester
East Jefferson General Hospital, Metairie
Texas Oncology - Dallas, Dallas
Texas Oncology - Denton North, Denton
The University of Texas - MD Anderson Cancer Center, Houston
Texas Oncology - San Antonio Northeast, San Antonio
Texas Oncology - McAllen, McAllen
Texas Oncology - Austin, Austin
Rocky Mountain Cancer Centers - Denver - Midtown, Denver
Huntsman Cancer Institute, Salt Lake City
Mayo Clinic Cancer Center (MCCC) - Phoenix, Phoenix
UCLA Ahmanson Biological Imaging Center, Santa Monica
Dana-Farber Cancer Institute, Boston
The Queen Elizabeth Hospital (TQEH), Adelaide
GenesisCare - North Shore, Alexandria
Blacktown Hospital, Blacktown
Peter MacCallum Cancer Centre, Melbourne
Fiona Stanley Hospital, Murdoch
Cliniques Universitaires Saint-Luc, Brussels
Hôpital Erasme, Brussels
Antwerp University Hospital, Edegem
Algemeen Ziekenhuis Maria Middelares, Ghent
Universitair Ziekenhuis Leuven, Leuven
AZ Nikolaas, Sint-Niklaas
London Health Sciences Centre, London
Centre Hospitalier de l'Universite de Montreal - Notre-Dame Hospital, Montreal
Jewish General Hospital, Montreal
The Ottawa Hospital - General Campus, Ottawa
Niagara Health System - St. Catharines General Site, St. Catharines
Princess Margaret Cancer Centre, Toronto
Sunnybrook Health Sciences Centre, Toronto
BC Cancer Agency Vancouver Centre, Vancouver
CHU Hopitaux de Bordeaux - Hôpital Haut-Lévêque, Bordeaux
CHRU de Tours - Hopital Trousseau, Chambray-lès-Tours
Centre Hospitalier Universitaire Dijon Bourgogne - L'Hopital General, Dijon
Groupe Hospitalier de l'Institut Catholique de Lille - Hopital Saint Vincent de Paul, Lille
CHU de Lyon - Groupement Hospitalier Edouard Herriot, Lyon
CHU de Nantes - Hôtel-Dieu, Nantes
Centre Eugène Marquis, Rennes
Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre, Strasbourg
Charite - UB - CVK - Medizinische Klinik, Berlin
Universitaetsklinikum Erlangen - Hautklinik, Erlangen
Universitätsklinikum Essen, Essen
Asklepios Klinik St. Georg, Hamburg
Universitätsklinikum Hamburg-Eppendorf (UKE), Hamburg
Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg, Heidelberg
Medizinischen Fakultät Mannheim der Universität Heidelberg, Mannheim
Universitätsklinikum Ulm, Ulm
SE ÁOK I. sz. Belgyógyászati Klinika, Budapest
Petz Aladár Megyei Oktató Kórház, Győr
Bács-Kiskun Megyei Kórház, Kecskemét
Szegedi Tudományegyetem; I.Belgyógyászati Klinika, Szeged
Rambam Medical Center, Haifa
Hadassah Medical Center (HMC) - Hadassah University Hospital (HUH) - Ein Kerem, Jerusalem
The Chaim Sheba Medical Center, Ramat Gan
Tel Aviv Sourasky Medical Center, Tel Aviv
Centro di Riferimento Oncologico (CRO), Aviano
Universita degli Studi di Bari - Aldo Moro, Bari
Azienda Ospedaliero - Universitaria di Bologna Policlinico S. Orsola - Malpighi, Bologna
ASST degli Spedali Civili di Brescia, Brescia
Universita degli Studi di Firenze - Azienda Ospedaliero - Universitaria Careggi - SC di Oncologia Medical, Florence
Universita Degli Studi di Genova - Center of Excellence for Biomedical Research (CEBR), Genova
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST IRCCS, Meldola
Istituto Clinico Humanitas, Milan
Azienda Ospedaliero - Universitaria di Modena Policlinico, Modena
IRCCS - Istituto Nazionale dei Tumori di Napoli Fondazione G. Pascale - Oncologia Addominale, Napoli
Istituto Oncologico Veneto - IRCCS, Padua
Azienda Ospedaliera Sant'Andrea, Roma
Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento, Verona
Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis, Amsterdam
Rijnstate Ziekenhuis - Arnhem, Arnhem
Maastricht UMC+, Maastricht
Erasmus MC, Rotterdam
Institutul Clinic Fundeni, Bucharest
"Institutul Oncologic Prof. Dr. Ion Chiricuţă Cluj Napoca", Cluj-Napoca
Medisprof SRL, Cluj-Napoca
Sigmedical Services S.R.L., Suceava
Complexo Hospitalario Universitario A Coruña, A Coruña
Hospital Universitari Vall d'Hebron - Vall d'Hebron Institut d'Oncologia (VHIO), Barcelona
Institut Catala d'Oncologia Hospitalet, Barcelona
Hospital General Universitario de Elche, Elche
Hospital Universitari de Girona Doctor Josep Trueta, Girona
Facultad de Medicina - Hospital Universitario Fundacion Jimenez Diaz (UAM-FJD) (Clinica de la Concepcion), Madrid
Hospital Universitario Fundación Alcorcón, Madrid
Hospital Universitario La Paz (HULP), Madrid
Hospital Universitario Ramón y Cajal, Madrid
MD Anderson Cancer Center - Madrid, Madrid
Hospital Universitario Virgen de la Victoria, Málaga
Hospital General Universitario Morales Meseguer, Murcia
Hospital Universitario Central de Asturias, Oviedo
Parc Taulí Sabadell Hospital Universitari, Sabadell
Hospital Universitario Marques de Valdecilla (HUMV), Santander
Lead Sponsor
Camurus AB
INDUSTRY